18F-FDG and 11C-choline uptake in proliferating tumor cells is dependent on the cell cycle in vitro

被引:11
作者
Roppongi, Motoi [1 ]
Izumisawa, Mitsuru [1 ]
Terasaki, Kazunori [2 ]
Muraki, Yasushi [3 ]
Shozushima, Masanori [1 ]
机构
[1] Iwate Med Univ, Sch Dent, Div Dent Radiol, 1-3-27 Chuodori, Morioka, Iwate 0208505, Japan
[2] Iwate Med Univ, Cyclotron Res Ctr, 348-58 Tomegamori, Takizawa, Iwate 0200603, Japan
[3] Iwate Med Univ, Sch Med, Dept Microbiol, Div Infect Dis & Immunol, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan
关键词
F-18-FDG; C-11-choline; Cell cycle; FUNCTIONAL-CHARACTERIZATION; CHOLINE TRANSPORTER; CANCER-CELLS; FDG-PET; SYNCHRONIZATION; FLUORINE-18-FLUORODEOXYGLUCOSE; MACROPHAGES; METABOLISM; EXPRESSION; CARCINOMA;
D O I
10.1007/s12149-018-01325-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Among different PET tracers, F-18-fludeoxyglucose (FDG) and C-11-choline are known to have a high tumor uptake correlated with a high mitotic index of tumor cells. Thus, the uptake of F-18-FDG and C-11-choline may be dependent on the cell cycle. In the present study, we examined the uptake of F-18-FDG and C-11-choline in cancer cell lines by cell cycle synchronization to clarify the biological properties of cancer cells with respect to each tracer. Methods HeLa S3 Cells were synchronized by the double thymidine (TdR) block methods. F-18-FDG and C-11-choline were administered to synchronized cells, and the radioactivity per cell was measured to compare the cellular uptake of the tracers during S, G2/M, and G1 phases. Flow cytometry (FCM) was performed to measure the proportion of cells in G1, S, and G2/M phases. Furthermore, the levels of glucose transporter 1 (GLUT1) and choline transporter-like protein 1 (CTL1) in the cell were evaluated by FCM. Results The uptake of F-18-FDG was the highest in S to G2/M phases, and markedly decreased in G1 phase. The uptake of C-11-choline reached its peak in G2/M, and decreased in G1 phase. The level of GLUT1 expression was similar to that of F-18-FDG uptake during the cell cycle, and the level of CTL1 expression was similar to that of C-11-choline uptake throughout the cell cycle. Conclusions In this in vitro study, we demonstrated that F-18-FDG and C-11-choline had the highest uptake in S to G2/M phases and in G2/M phase, respectively, with a rapid decrease in G1 phase. These findings suggest that F-18-FDG and C-11-choline have a high accumulation in tumor cells with a high mitotic index. Furthermore, our study suggests that the expression of GLUT1 and CTL1 has cell cycle dependence, and the changes of F-18-FDG and C-11-choline accumulation seem to be caused by the above properties of these transporters.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 50 条
  • [41] Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading A Meta-analysis
    Katsanos, Aristeidis H.
    Alexiou, George A.
    Fotopoulos, Andreas D.
    Jabbour, Pascal
    Kyritsis, Athanasios P.
    Sioka, Chrissa
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (11) : 864 - 869
  • [42] Inflammatory Cytokines and Hypoxia Contribute to 18F-FDG Uptake by Cells Involved in Pannus Formation in Rheumatoid Arthritis
    Matsui, Tamiko
    Nakata, Norihito
    Nagai, Shigenori
    Nakatani, Akira
    Takahashi, Miwako
    Momose, Toshimitsu
    Ohtomo, Kuni
    Koyasu, Shigeo
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) : 920 - 926
  • [43] Effects of Intratumoral Inflammatory Process on 18F-FDG Uptake: Pathologic and Comparative Study with 18F-Fluoro-α-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma
    Kim, Mai
    Achmad, Arifudin
    Higuchi, Tetsuya
    Arisaka, Yukiko
    Yokoo, Hideaki
    Yokoo, Satoshi
    Tsushima, Yoshito
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01) : 16 - 21
  • [44] Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns
    Tan, Shan
    Zhang, Hao
    Zhang, Yongxue
    Chen, Wengen
    D'Souza, Warren D.
    Lu, Wei
    MEDICAL PHYSICS, 2013, 40 (10)
  • [45] 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
    Guan, Jian
    Xiao, Nan J.
    Chen, Min
    Zhou, Wen L.
    Zhang, Yao W.
    Wang, Shuang
    Dai, Yong M.
    Li, Lu
    Zhang, Yue
    Li, Qin Y.
    Li, Xiang Z.
    Yang, Mi
    Wu, Hu B.
    Chen, Long H.
    Liu, Lai Y.
    MEDICINE, 2016, 95 (30)
  • [46] The prognostic significance of intratumoral heterogeneity of 18F-FDG uptake in patients with oral cavity squamous cell carcinoma
    Kimura, Masashi
    Kato, Isao
    Ishibashi, Kenichiro
    Shibata, Akio
    Nishiwaki, Shusuke
    Fukumura, Masahiro
    Sone, Yasuhiro
    Nagao, Toru
    Umemura, Masahiro
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 114 : 99 - 104
  • [47] Imaging a pancreatic carcinoma xenograft model with 11C-acetate: a comparison study with 18F-FDG
    Zhao, Chunlei
    Chen, Zhanhong
    Ye, Xiaojuan
    Zhang, Ying
    Zhan, Hongwei
    Aburano, Tamio
    Tian, Mei
    Zhang, Hong
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (12) : 971 - 977
  • [48] Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer
    Kaira, Kyoichi
    Serizawa, Masakuni
    Koh, Yasuhiro
    Takahashi, Toshiaki
    Yamaguchi, Aiko
    Hanaoka, Hirofumi
    Oriuchi, Noboru
    Endo, Masahiro
    Ohde, Yasuhisa
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    LUNG CANCER, 2014, 83 (02) : 197 - 204
  • [49] The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer
    Lee, Jeong Won
    Kim, Eun Young
    Kim, Dae Joon
    Lee, Jae-Hoon
    Kang, Won Jun
    Lee, Jong Doo
    Yun, Mijin
    EUROPEAN RADIOLOGY, 2016, 26 (12) : 4515 - 4523
  • [50] Regulation of Uptake of 18F-FDG by a Follicular Human Thyroid Cancer Cell Line with Mutation-Activated K-Ras
    Prante, Olaf
    Maschauer, Simone
    Fremont, Valerie
    Reinfelder, Julia
    Stoehr, Robert
    Szkudlinski, Mariusz
    Weintraub, Bruce
    Hartmann, Arndt
    Kuwert, Torsten
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (08) : 1364 - 1370